Epitomee Medical Current Valuation vs. Shares Outstanding

EPIT Stock   938.20  30.20  3.33%   
Taking into consideration Epitomee Medical's profitability measurements, Epitomee Medical may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Epitomee Medical's ability to earn profits and add value for shareholders.
For Epitomee Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Epitomee Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Epitomee Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Epitomee Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Epitomee Medical over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Epitomee Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Epitomee Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Epitomee Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Epitomee Medical Shares Outstanding vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Epitomee Medical's current stock value. Our valuation model uses many indicators to compare Epitomee Medical value to that of its competitors to determine the firm's financial worth.
Epitomee Medical is rated # 5 in current valuation category among its peers. It also is rated # 5 in shares outstanding category among its peers creating about  0.09  of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Epitomee Medical is roughly  11.46 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Epitomee Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Epitomee Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Epitomee Current Valuation vs. Competition

Epitomee Medical is rated # 5 in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Devices industry is currently estimated at about 1.91 Billion. Epitomee Medical retains roughly 339.18 Million in current valuation claiming about 18% of all equities under Medical Devices industry.

Epitomee Shares Outstanding vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Epitomee Medical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
339.18 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Epitomee Medical

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
29.58 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Epitomee Shares Outstanding Comparison

Epitomee Medical is rated # 4 in shares outstanding category among its peers.

Epitomee Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Epitomee Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Epitomee Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Epitomee Medical's important profitability drivers and their relationship over time.

Use Epitomee Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Epitomee Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Epitomee Medical will appreciate offsetting losses from the drop in the long position's value.

Epitomee Medical Pair Trading

Epitomee Medical Pair Trading Analysis

The ability to find closely correlated positions to Epitomee Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Epitomee Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Epitomee Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Epitomee Medical to buy it.
The correlation of Epitomee Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Epitomee Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Epitomee Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Epitomee Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Epitomee Medical position

In addition to having Epitomee Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Synthetics Thematic Idea Now

Synthetics
Synthetics Theme
Companies involved in production of silicon and other synthetic products . The Synthetics theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Synthetics Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Epitomee Stock

To fully project Epitomee Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Epitomee Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Epitomee Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Epitomee Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Epitomee Medical investors may work on each financial statement separately, they are all related. The changes in Epitomee Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Epitomee Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.